Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Blood Dyscrasia Patients”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05036863
What this trial is testing

Feasibility Study of an ePRO Monitoring for Patients With Multiple Myeloma and Development of Item Lists

Who this might be right for
Multiple Myeloma
Medical University Innsbruck 39
Early research (Phase 1)Study completedNCT01378416
What this trial is testing

Pharmacokinetic Trial of Decitabine (Dacogen) Administered as a 3-hour Infusion to Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Who this might be right for
Leukemia
Eisai Inc. 16
Not applicableUnknownNCT02061033
What this trial is testing

Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease

Who this might be right for
Hemophilia AHemophilia BVon Willebrand's Disease
Karolinska University Hospital 180
Large-scale testing (Phase 3)Looking for participantsNCT07203352
What this trial is testing

Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL

Who this might be right for
Acute Lymphoblastic Leukemia
Nanfang Hospital, Southern Medical University 154
Early research (Phase 1)Study completedNCT04015492
What this trial is testing

Study to Compare How the Body Distributes and Excretes the Drugs Jivi (BAY 94-9027) and Adynovi in Patients With Severe Hemophilia A (Bleeding Disorder Resulting From a Lack of Blood Clotting Factor VIII)

Who this might be right for
Hemophilia A
Bayer 18
Not applicableUnknownNCT04743544
What this trial is testing

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Who this might be right for
Adverse Drug Reactions
Dokuz Eylul University 62
Not applicableUnknownNCT02341547
What this trial is testing

Effectiveness of a Biosimilar Epoetin Alfa in Stable 'End Stage Renal Failure'

Who this might be right for
End Stage Renal FailureAnaemia
Penang Hospital, Malaysia 44
Not applicableStudy completedNCT04808349
What this trial is testing

Safety and Efficacy in a ReAl-Life Study in Patients With Haemophilia Treated wIth NovoEight® for Surgery

Who this might be right for
Hemophilia
Nantes University Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT01685021
What this trial is testing

Study of Fc-Optimized Anti-CD19 Antibody (MOR00208) to Treat B-cell Acute Lymphoblastic Leukemia(B-ALL)

Who this might be right for
Acute Lymphoblastic Leukemia
MorphoSys AG 22
Not applicableStudy completedNCT05360706
What this trial is testing

Study of AAV5-hFIX in Severe or Moderately Severe Haemophilia B

Who this might be right for
Hemophilia B
CSL Behring 9
Testing effectiveness (Phase 2)Study completedNCT00944684
What this trial is testing

High Dose Ribavirin in the Treatment of Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of Bern 32
Early research (Phase 1)Study completedNCT02594384
What this trial is testing

A Phase I Dose Escalation Study of the Safety and Pharmacokinetics of LAM-002A In Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, Non-Hodgkin; Leukemia, Chronic Lymphocytic
OrphAI Therapeutics 62
Testing effectiveness (Phase 2)Study completedNCT01237249
What this trial is testing

Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose Dexamethasone

Who this might be right for
Multiple Myeloma
PETHEMA Foundation 250
Testing effectiveness (Phase 2)Study completedNCT00916058
What this trial is testing

Conditioning Regimen of Bendamustine and Melphalan Followed by Transplant in Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Weill Medical College of Cornell University 57
Large-scale testing (Phase 3)Looking for participantsNCT07297329
What this trial is testing

Evaluate the Safety and Efficacy of SCTC21C in Combination With Bortezomib, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Who this might be right for
Multiple Myeloma (MM)
Sinocelltech Ltd. 292
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Testing effectiveness (Phase 2)Study completedNCT01295307
What this trial is testing

Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 86
Early research (Phase 1)Ended earlyNCT00928200
What this trial is testing

Erwinase for Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (IND 104224)

Who this might be right for
Relapsed Acute Lymphoblastic LeukemiaAllergy to PEG e.Coli AsparaginaseAllergy to Native e.Coli Asparaginase
Therapeutic Advances in Childhood Leukemia Consortium 1
Testing effectiveness (Phase 2)Study completedNCT00045136
What this trial is testing

Chemotherapy, Holmium Ho 166 DOTMP, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Poniard Pharmaceuticals
Early research (Phase 1)Study completedNCT00002946
What this trial is testing

Penclomedine in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 30
Next Page